Go Pro

Health Catalyst (HCAT) 10K Form and Latest SEC Filings 2026

Health Catalyst logo
$1.59 +0.06 (+3.92%)
Closing price 08/24/2026 04:00 PM Eastern
Extended Trading
$1.60 +0.00 (+0.31%)
As of 08/24/2026 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Health Catalyst SEC Filings & Recent Activity

Health Catalyst (NASDAQ:HCAT) has submitted 623+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Health Catalyst's financial statements. The most recent filing was a Form 10-Q submitted on August 6, 2026.

Form 4
Health Catalyst, Inc. Reports Ownership Change on Jul. 20, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
Health Catalyst Files Quarterly Report on Aug. 6, 2026

The 10-Q contains Health Catalyst's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Health Catalyst SEC Filing History

Browse Health Catalyst's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/06/2026 3:58 PM
Health Catalyst (1636422) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/21/2026 10:06 AM
Health Catalyst (1636422) Subject
Impax Asset Management Group plc (1749768) Filed by
Form SCHEDULE 13G
07/20/2026 4:18 PM
Health Catalyst (1636422) Issuer
Spencer Justin (1397180) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 4:19 PM
Health Catalyst (1636422) Issuer
Nelson Steven H (1320490) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 4:19 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 4:19 PM
Health Catalyst (1636422) Issuer
Hoggard Green Jill (2046471) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 2:55 PM
Health Catalyst (1636422) Subject
Palogic Value Management, L.P. (1532943) Filed by
Form SCHEDULE 13D
06/15/2026 3:42 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 4:11 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2026 6:12 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13D/A
06/04/2026 8:10 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2026 6:42 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:45 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:45 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:46 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:46 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 4:23 PM
Health Catalyst (1636422) Filer
Form DEFA14A
06/01/2026 4:35 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 4:36 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 4:36 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 4:37 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2026 4:03 PM
Health Catalyst (1636422) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2026 4:16 PM
Health Catalyst (1636422) Issuer
Nelson Steven H (1320490) Reporting
Form 3
Initial statement of beneficial ownership of securities  
05/04/2026 4:17 PM
Health Catalyst (1636422) Issuer
Nelson Steven H (1320490) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2026 4:25 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2026 3:33 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2026 4:19 PM
Health Catalyst (1636422) Filer
Form 10-K/A
04/27/2026 8:00 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2026 8:31 AM
Health Catalyst (1636422) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/13/2026 7:09 PM
First Light Asset Management, LLC (1600004) Filed by
Health Catalyst (1636422) Subject
Form SCHEDULE 13D/A
03/13/2026 7:13 AM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 4:10 PM
Health Catalyst (1636422) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2026 3:58 PM
Health Catalyst (1636422) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2026 7:39 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 5:47 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:47 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:48 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:48 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:48 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 6:14 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:15 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
03/02/2026 6:15 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:16 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:16 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:17 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:35 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:37 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:28 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:29 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:30 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:31 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2026 6:03 PM
Gallagher Duncan (1780880) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 12:04 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13D/A
02/18/2026 7:59 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 3:15 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2026 7:39 AM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13D
01/14/2026 7:27 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13G/A
01/12/2026 3:26 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 4:25 PM
Health Catalyst (1636422) Subject
Stoney Lonesome HF LP (2014854) Filed by
Form SCHEDULE 13G
12/09/2025 5:37 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2025 5:37 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2025 3:24 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2025 3:08 PM
Health Catalyst (1636422) Subject
Larson-Green Julie (1796545) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2025 3:19 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:19 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:19 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:20 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:20 PM
Gallagher Duncan (1780880) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:21 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:16 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2025 6:10 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2025 7:51 PM
Health Catalyst (1636422) Subject
Ross David Coy (2074748) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:43 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:44 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:44 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:46 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:47 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 3:41 PM
First Light Asset Management, LLC (1600004) Filed by
Health Catalyst (1636422) Subject
Form SCHEDULE 13G/A
11/10/2025 3:17 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 3:23 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 3
Initial statement of beneficial ownership of securities  
09/26/2025 3:25 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025 4:20 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2025 3:52 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13G
09/05/2025 3:53 PM
Gallagher Duncan (1780880) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025 3:54 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:55 PM
Health Catalyst (1636422) Issuer
Ross David Coy (2074748) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Health Catalyst (1636422) Issuer
LeSueur Daniel (2013388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
09/04/2025 5:34 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Health Catalyst SEC Filings - Frequently Asked Questions

Health Catalyst (HCAT) has submitted 623+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Health Catalyst's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Health Catalyst's financial statements page.

The most recent filing was a Form 10-Q submitted on August 6, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:HCAT are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/6/2026. New filings are added as they're published.
From Our Partners